Back
Agios Pharmaceuticals, Inc. 10K Form
Sell
6
AGIO
Agios Pharmaceuticals, Inc.
Last Price:
$27.43
Seasonality Move:
8.29%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-02 | 10Q | AGIO/Agios Pharmaceuticals, Inc. Quarterly |
| 2023-11-02 | 10Q | AGIO/Agios Pharmaceuticals, Inc. Quarterly |
| 2023-08-03 | 10Q | AGIO/Agios Pharmaceuticals, Inc. Quarterly |
| 2023-05-04 | 10Q | AGIO/Agios Pharmaceuticals, Inc. Quarterly |
| 2022-11-03 | 10Q | AGIO/Agios Pharmaceuticals, Inc. Quarterly |
| 2022-08-04 | 10Q | AGIO/Agios Pharmaceuticals, Inc. Quarterly |
Receive AGIO News And Ratings
See the #1 stock for the next 7 days that we like better than AGIO
AGIO Financial Statistics
Sales & Book Value
| Annual Sales: | $36.5M |
|---|---|
| Cash Flow: | $-89.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $22.04 |
| Price / Book: | 1.25 |
Profitability
| EPS (TTM): | -6.95550 |
|---|---|
| Net Income (TTM): | $-401.3M |
| Gross Margin: | $26.7M |
| Return on Equity: | -27.53% |
| Return on Assets: | -25.5% |
Agios Pharmaceuticals, Inc. Earnings Forecast
Key Agios Pharmaceuticals, Inc. Financial Ratios
-
The Gross Profit Margin over the past 12 years for AGIO is 73.10%.
-
The Selling, General & Administrative Expenses for AGIO have been equal to 429.57% of Gross Profit Margin.
-
The Research & Development expenses have been 810.00% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of AGIO is 1,845.92% of Total Revenues.
-
Per Share Earnings over the last 14 years have been positive in 5 years.
Agios Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | AGIO |
| CUSIP: | 00847X |
| Website: | agios.com |
Debt
| Debt-to-Equity Ratio: | 0.03 |
|---|---|
| Current Ratio: | 13.82 |
| Quick Ratio: | 12.81 |
Price-to-Earnings
| Trailing P/E Ratio: | 2.36 |
|---|---|
| Forward P/E Ratio: | 2.01 |
AGIO Technical Analysis vs Fundamental Analysis
Sell
6
Agios Pharmaceuticals, Inc. (AGIO)
is a Sell
Is Agios Pharmaceuticals, Inc. a Buy or a Sell?
-
Agios Pharmaceuticals, Inc. stock is rated a SellThe current Agios Pharmaceuticals, Inc. [AGIO] share price is $27.42. The Score for AGIO is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.